β-Asarone inhibits gastric cancer cell proliferation.
暂无分享,去创建一个
Xiangxiong Zhang | Min Chen | Jian Wu | Jin-Yong Zhou | Qingmin Sun | X. Zou | Xing-xing Zhang | Sheng-Lin Liu
[1] 张晓杰. β-Asarone Reverses Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior and Promotes Hippocampal Neurogenesis in Rats , 2014 .
[2] Jing Yang,et al. Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.
[3] Chunlan Hong,et al. Beta-asarone, a major component of Acorus tatarinowii Schott, attenuates focal cerebral ischemia induced by middle cerebral artery occlusion in rats , 2013, BMC Complementary and Alternative Medicine.
[4] Li Zhou,et al. Identification of Insecticidal Constituents of the Essential Oil of Acorus calamus Rhizomes against Liposcelis bostrychophila Badonnel , 2013, Molecules.
[5] Jian Wu,et al. Beta-asarone induces LoVo colon cancer cell apoptosis by up-regulation of caspases through a mitochondrial pathway in vitro and in vivo. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[6] M. Tez,et al. Gastric carcinogenesis. , 2012, World journal of gastroenterology.
[7] R. Seiler,et al. MMP-2 and MMP-9 in lymph-node-positive bladder cancer , 2011, Journal of Clinical Pathology.
[8] D. Lauffenburger,et al. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. , 2011, Frontiers in bioscience.
[9] A. Paradiso,et al. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. , 2010, Anticancer research.
[10] D. Yoon,et al. Asarone inhibits adipogenesis and stimulates lipolysis in 3T3-L1 adipocytes. , 2010, Cellular and molecular biology.
[11] Seamus J. Martin,et al. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. , 2009, Molecular cell.
[12] M. Eshraghi,et al. Apoptosis and cancer: mutations within caspase genes , 2009, Journal of Medical Genetics.
[13] E. Neilson,et al. Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.
[14] H. Kitayama,et al. RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin* , 2009, Journal of Biological Chemistry.
[15] J. Thiery,et al. The physiology and pathology of the EMT Meeting on the Epithelial – Mesenchymal Transition , 2008 .
[16] M. Matsuura,et al. S. cerevisiae induces apoptosis in human metastatic breast cancer cells by altering intracellular Ca2+ and the ratio of Bax and Bcl-2. , 2008, International journal of oncology.
[17] C. Brooks,et al. Regulation of Mitochondrial Morphological Dynamics During Apoptosis by Bcl-2 family proteins: A Key in Bak? , 2007, Cell cycle.
[18] M. Tada,et al. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. , 2007, Lung cancer.
[19] David M. Thomas,et al. RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer , 2007, Cancer and Metastasis Reviews.
[20] M. Betenbaugh,et al. Links between metabolism and apoptosis in mammalian cells: applications for anti-apoptosis engineering. , 2007, Metabolic engineering.
[21] R. Moriggl,et al. Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction , 2007 .
[22] D. Kardamakis,et al. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. , 2007, In vivo.
[23] R. Moriggl,et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. , 2007, Neoplasia.
[24] Hong Zhang,et al. Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis. , 2006, International journal of oncology.
[25] T. Fan,et al. Caspase family proteases and apoptosis. , 2005, Acta biochimica et biophysica Sinica.
[26] J. Narula,et al. Apoptosis and heart failure: clinical relevance and therapeutic target. , 2005, Journal of molecular and cellular cardiology.